Institutional members access full text with Ovid®

Share this article on:

Clinical Prescribing (and Off-Label Use) in a Second-Best World

Alexander, G. Caleb MD, MS*†‡§

doi: 10.1097/MLR.0b013e3181d60408
Editorial

From the *Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, IL; †MacLean Center for Clinical Medical Ethics, University of Chicago, Chicago, IL; ‡Center for Health and the Social Sciences, University of Chicago, Chicago, IL; and §Department of Pharmacy Administration and Practice, University of Illinois at Chicago, Chicago, IL.

Supported by the Agency for Healthcare Research and Quality (K08 HS15699–01A1).

The funding source had no role in manuscript preparation, review, or final approval.

Dr. Alexander serves as a consultant to IMS Health and has received grant funding from Pfizer.

Reprints: G. Caleb Alexander, MD, MS, The University of Chicago, 5841 S. Maryland, MC 2007, Chicago, IL 60637. E-mail: galexand@uchicago.edu.

© 2010 Lippincott Williams & Wilkins, Inc.